Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study.

Published on Sep 1, 2021in The Lancet Child & Adolescent Health11.288
· DOI :10.1016/S2352-4642(21)00193-0
Stephen Ray4
Estimated H-index: 4
(Malawi-Liverpool-Wellcome Trust Clinical Research Programme),
Omar Abdel-Mannan2
Estimated H-index: 2
(UCL Institute of Neurology)
Summary null null Background null The spectrum of neurological and psychiatric complications associated with paediatric SARS-CoV-2 infection is poorly understood. We aimed to analyse the range and prevalence of these complications in hospitalised children and adolescents. null null null Methods null We did a prospective national cohort study in the UK using an online network of secure rapid-response notification portals established by the CoroNerve study group. Paediatric neurologists were invited to notify any children and adolescents (age null null null null Findings null Between April 2, 2020, and Feb 1, 2021, 52 cases were identified; in England, there were 51 cases among 1334 children and adolescents hospitalised with COVID-19, giving an estimated prevalence of 3·8 (95% CI 2·9–5·0) cases per 100 paediatric patients. 22 (42%) patients were female and 30 (58%) were male; the median age was 9 years (range 1–17). 36 (69%) patients were Black or Asian, 16 (31%) were White. 27 (52%) of 52 patients were classified into the COVID-19 neurology group and 25 (48%) were classified into the PIMS-TS neurology group. In the COVID-19 neurology group, diagnoses included status epilepticus (n=7), encephalitis (n=5), Guillain-Barre syndrome (n=5), acute demyelinating syndrome (n=3), chorea (n=2), psychosis (n=2), isolated encephalopathy (n=2), and transient ischaemic attack (n=1). The PIMS-TS neurology group more often had multiple features, which included encephalopathy (n=22 [88%]), peripheral nervous system involvement (n=10 [40%]), behavioural change (n=9 [36%]), and hallucinations at presentation (n=6 [24%]). Recognised neuroimmune disorders were more common in the COVID-19 neurology group than in the PIMS-TS neurology group (13 [48%] of 27 patients vs 1 [ null null null Interpretation null This study identified key differences between those with a primary neurological disorder versus those with PIMS-TS. Compared with patients with a primary neurological disorder, more patients with PIMS-TS needed intensive care, but outcomes were similar overall. Further studies should investigate underlying mechanisms for neurological involvement in COVID-19 and the longer-term outcomes. null null null Funding null UK Research and Innovation, Medical Research Council, Wellcome Trust, National Institute for Health Research.
#1Kerri L. LaRovere (Harvard University)H-Index: 12
#2Becky J. Riggs (Johns Hopkins University)H-Index: 9
Last. Charlotte V. Hobbs (University of Mississippi)H-Index: 6
view all 48 authors...
Importance Coronavirus disease 2019 (COVID-19) affects the nervous system in adult patients. The spectrum of neurologic involvement in children and adolescents is unclear. Objective To understand the range and severity of neurologic involvement among children and adolescents associated with COVID-19. Setting, Design, and Participants Case series of patients (age Exposures Severe acute respiratory syndrome coronavirus 2. Main Outcomes and Measures Type and severity of neurologic involvement, labo...
#2Luwaiza MirzaH-Index: 1
#3Michael J. CarterH-Index: 16
Last. Ming K. LimH-Index: 59
view all 21 authors...
Objective Pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) is a severe immune-mediated disorder. We aim to report the neurologic features of children with PIMS-TS. Methods We identified children presenting to a large children9s hospital with PIMS-TS from March to June 2020 and performed a retrospective medical note review, identifying clinical and investigative features alongside short-term outcome of children presenting with neurologic symptoms. Result...
#1Camilla Lindan (UCSF: University of California, San Francisco)H-Index: 4
#2Kshitij Mankad (GOSH: Great Ormond Street Hospital)H-Index: 22
Last. Douglas AldenH-Index: 1
view all 81 authors...
Summary Background The CNS manifestations of COVID-19 in children have primarily been described in case reports, which limit the ability to appreciate the full spectrum of the disease in paediatric patients. We aimed to identify enough cases that could be evaluated in aggregate to better understand the neuroimaging manifestations of COVID-19 in the paediatric population. Methods An international call for cases of children with encephalopathy related to severe acute respiratory syndrome coronavir...
#1Tom Solomon (NIHR: National Institute for Health Research)H-Index: 76
As the COVID-19 pandemic developed and neurological manifestations were reported, concern grew that SARS-CoV-2 might directly invade neuronal cells. However, research throughout the year to address this concern has revealed a different story with inflammatory processes at its centre.
#1Luca Zombori (Barts Health NHS Trust)H-Index: 1
#2Melody Bacon (Barts Health NHS Trust)H-Index: 1
Last. Michael Yoong (Barts Health NHS Trust)H-Index: 1
view all 7 authors...
Symptoms of COVID-19, as reported during the SARS-CoV-2 pandemic in 2019-2020, are primarily respiratory and gastrointestinal, with sparse reports on neurological manifestations. We describe the case of a 17-year old female with Cornelia de Lange syndrome and well controlled epilepsy, who sustained significant cortical injury during a COVID-19 associated multi-inflammatory syndrome.
#1Suman KushwahaH-Index: 11
#2Vaibhav SethH-Index: 2
Last. Aldrin AnthonyH-Index: 2
view all 9 authors...
The neurotrophic potential of SARS-CoV-2 virus is manifesting as various neurological disorders in the present pandemic. Nervous system involvement can be due to the direct action of the virus on the brain tissue or due to an indirect action through the activation of immune-mediated mechanisms. This study will discuss the detailed systematically evaluated clinical profile and relevant investigations and outcome of 14 laboratory confirmed SARS-CoV-2 positive patients presenting with neurological ...
#1Jakob Matschke (UHH: University of Hamburg)H-Index: 28
#2Marc Lütgehetmann (UHH: University of Hamburg)H-Index: 41
Last. Markus Glatzel (UHH: University of Hamburg)H-Index: 63
view all 22 authors...
Summary Background Prominent clinical symptoms of COVID-19 include CNS manifestations. However, it is unclear whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, gains access to the CNS and whether it causes neuropathological changes. We investigated the brain tissue of patients who died from COVID-19 for glial responses, inflammatory changes, and the presence of SARS-CoV-2 in the CNS. Methods In this post-mortem case series, we investigated the...
#1Ross W. Paterson (UCL: University College London)H-Index: 27
#2Rachel Brown (UCL: University College London)H-Index: 6
Last. Laura Zambreanu (UCL: University College London)H-Index: 2
view all 56 authors...
Preliminary clinical data indicate that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with neurological and neuropsychiatric illness. Responding to this, a weekly virtual coronavirus disease 19 (COVID-19) neurology multi-disciplinary meeting was established at the National Hospital, Queen Square, in early March 2020 in order to discuss and begin to understand neurological presentations in patients with suspected COVID-19-related neurological disorders. Deta...
#1Costantino Iadecola (Cornell University)H-Index: 122
#2Josef Anrather (Cornell University)H-Index: 65
Last. Hooman Kamel (Cornell University)H-Index: 58
view all 3 authors...
Neurological complications have emerged as a significant cause of morbidity and mortality in the ongoing COVID-19 pandemic. Beside respiratory insufficiency, many hospitalized patients exhibit neurological manifestations ranging from headache and loss of smell, to confusion and disabling strokes. COVID-19 is also anticipated to take a toll on the nervous system in the long term. Here, we will provide a critical appraisal of the potential for neurotropism and mechanisms of neuropathogenesis of SA...
Cited By3
#1Alicia M. Alcamo (Children's Hospital of Philadelphia)H-Index: 1
#3Hari Krishnan Kanthimathinathan (University of Birmingham)H-Index: 9
Last. Ericka L. Fink (University of Pittsburgh)H-Index: 26
view all 5 authors...
PURPOSE OF REVIEW: The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic has overwhelmed the global community, negatively impacting patient health and research efforts; associated neurological manifestations are a significant cause of morbidity. This review outlines the worldwide epidemiology of neurologic manifestations of different SARS-CoV-2 clinical pediatric phenotypes, including acute coronavirus disease 2019 (COVID-19), multisystem inflammatory syndrome in children (MI...
#1Menno Baumann (University of Applied Sciences Düsseldorf)
Since the beginning of the COVID-19 pandemic, much research has been done on the psycho-social consequences, especially for children, adolescents and families. In the long run, there is a large set of quantitative data available. However, these still seem to be not well understood. Theoretical classifications of the evidence also diagnostic tools still seem to be open. This paper elaborates a possible systematisation based on theoretical models of systemic self-organisation theories. This leads ...
#1Alex Mun-Ching Wong (CGU: Chang Gung University)H-Index: 15
#2Cheng-Hong Toh (CGU: Chang Gung University)H-Index: 19
Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has affected over 200 million people globally (including over 30 million people in the United States), with children comprising 12.9% of reported cases in the United States. In children, COVID-19 infection appears to be associated with mild respiratory symptoms; however, serious neurological complications may occur in conjunction with multisystem inflammatory syndrome. A wide spectrum of neurological diseases have been observed in childre...
#1Deepti Gurdasani (QMUL: Queen Mary University of London)H-Index: 20
#2Samir Bhatt (ICL: Imperial College London)H-Index: 67
Last. Christina Pagel (UCL: University College London)H-Index: 25
view all 18 authors...
ObjectiveTo offer a quantitative risk–benefit analysis of two doses of SARS-CoV-2 vaccination among adolescents in England.SettingEngland.DesignFollowing the risk–benefit analysis methodology carri...
#1Annaleise R Howard-Jones (Nepean Hospital)H-Index: 8
#2David Burgner (Royal Children's Hospital)H-Index: 60
Last. Philip N Britton (Children's Hospital at Westmead)H-Index: 19
view all 16 authors...
The global disruption of the COVID-19 pandemic has impacted the life of every child either directly or indirectly. This review explores the pathophysiology, immune response, clinical presentation and treatment of COVID-19 in children, summarising the most up-to-date data including recent developments regarding variants of concern. The acute infection with SARS-CoV-2 is generally mild in children, whilst the post-infectious manifestations, including paediatric inflammatory multisystem syndrome te...
#1Nivya Shree (Bangalore Medical College and Research Institute)
#2Anitha Kommalur (Bangalore Medical College and Research Institute)H-Index: 3
Last. Ashray Sudarshan Patel (Bangalore Medical College and Research Institute)
view all 9 authors...
The coronavirus disease 2019 (COVID-19) in children has been shown to have lower morbidity and mortality in children as compared with adults. The neurological complications related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are increasingly reported in children, yet the cerebrovascular complications are rare. We report a case of a toddler who presented with right-sided hemiparesis and motor aphasia, with an antecedent history suggestive of COVID-19 infection. The child teste...
#1Trang T. Le (UPenn: University of Pennsylvania)H-Index: 11
#2Alba Gutiérrez-Sacristán (Harvard University)H-Index: 9
Last. Kee Yuan NgiamH-Index: 13
view all 22 authors...
Neurological complications worsen outcomes in COVID-19. To define the prevalence of neurological conditions among hospitalized patients with a positive SARS-CoV-2 reverse transcription polymerase chain reaction test in geographically diverse multinational populations during early pandemic, we used electronic health records (EHR) from 338 participating hospitals across 6 countries and 3 continents (January-September 2020) for a cross-sectional analysis. We assessed the frequency of International ...
Last. Martin Krsak (Anschutz Medical Campus)H-Index: 7
view all 10 authors...
Over 10% of COVID-19 convalescents report post-COVID-19 complications, namely, 'long COVID' or 'post-COVID syndrome,' including a number of neuro-psychiatric symptoms. The pathophysiology of COVID-19 in the central nervous system is poorly understood but may represent post-COVID injury, ongoing sterile maladaptive inflammation, or SARS-CoV-2 persistence. We describe a long COVID patient with SARS-CoV-2 RNA in the cerebrospinal fluid, which seems important, specifically due to recent reports of g...
#1Wai M. Oo (UTAS: University of Tasmania)
#2Pradeep Giri (Launceston General Hospital)
Last. Aaron de Souza (Launceston General Hospital)H-Index: 8
view all 3 authors...
Abstract null null The emergence of the coronavirus 2019 (COVID-19) pandemic has presented an unprecedented global challenge. Vaccines against COVID have been developed to date. Covid-19 has been linked with the development of Guillain-Barre Syndrome, a rare immune-mediated demyelinating neuropathy. We report three cases of Guillain-Barre Syndrome and one case of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), presenting to a Tasmanian hospital, and review 15 other reported cases and d...
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.